Ypsomed Holding AG (YPSN.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
At close: 05:30PM CEST
| Previous close | 401.00 |
| Open | 407.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 397.50 - 407.00 |
| 52-week range | 243.50 - 416.00 |
| Volume | |
| Avg. volume | 13,234 |
| Market cap | 5.48B |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | 69.95 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.00 (0.50%) |
| Ex-dividend date | 28 June 2024 |
| 1y target est | N/A |
- Business Wire
Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease
WALTHAM, Mass., October 26, 2023--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, and Ypsomed AG (SIX: YPSN), the leading developer and manufacturer of injection and infusion systems for self-medication have signed a supply agreement for Ypsomed’s customizable YpsoMate 2.25 autoinjector pen device with a fill volume of 2.0 milliliters.
© 2024 Yahoo. All rights reserved.